Severe thyrotoxicosis induced by tislelizumab: a case report and literature review

Huo, LM; Wang, C; Ding, HX; Shi, XL; Shan, B; Zhou, RY; Liang, P; Hou, J

Liang, P; Hou, J (通讯作者),Hebei Med Univ, Hosp 4, Dept Pharm, Shijiazhuang, Peoples R China.

FRONTIERS IN ONCOLOGY, 2023; 13 ():

Abstract

Immune checkpoint inhibitors (ICIs) have made significant breakthroughs in the treatment of a variety of malignancies. As its use increases, the uniqu......

Full Text Link